Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals available in the treatment of countless medical conditions. However, the success of ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for manufacturing cell therapies. Scott R. Burger ...
Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...
Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results